These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9886301)

  • 1. Evaluation of cardiac status in iron-loaded thalassaemia patients following bone marrow transplantation: improvement in cardiac function during reduction in body iron burden.
    Mariotti E; Angelucci E; Agostini A; Baronciani D; Sgarbi E; Lucarelli G
    Br J Haematol; 1998 Dec; 103(4):916-21. PubMed ID: 9886301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
    Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Giardini C; Gaziev D; Polchi P
    Blood; 1997 Aug; 90(3):994-8. PubMed ID: 9242528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early iron reduction programme for thalassaemia patients after bone marrow transplantation.
    Li CK; Lai DH; Shing MM; Chik KW; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Mar; 25(6):653-6. PubMed ID: 10734300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Gaziev D; Erer B; La Nasa G; Barbanti I
    Br J Haematol; 1995 Apr; 89(4):868-73. PubMed ID: 7772524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload.
    Luckie M; Irwin B; Nair S; Greenwood J; Khattar R
    Eur J Echocardiogr; 2009 Jun; 10(4):509-12. PubMed ID: 19091793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
    Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation.
    Muretto P; Angelucci E; Lucarelli G
    Ann Intern Med; 2002 May; 136(9):667-72. PubMed ID: 11992302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac study by dobutamine stress echocardiography in thalassemic patients.
    Mariotti E; Agostini A; Angelucci E; Cesaroni P; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():14-5. PubMed ID: 8374553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation.
    Meo A; Ruggeri A; La Rosa MA; Zanghì L; Morabito N; Duca L
    Hemoglobin; 2006; 30(1):131-7. PubMed ID: 16540426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia.
    Isma'eel H; Chafic AH; El Rassi F; Inati A; Koussa S; Daher R; Gharzuddin W; Alam S; Taher A
    Am J Cardiol; 2008 Aug; 102(3):363-7. PubMed ID: 18638603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive cardiac assessment in beta-thalassaemia major.
    Ong ML; Hatle LK; Lai VM; Bosco J
    Int J Clin Pract; 2002 Jun; 56(5):345-8. PubMed ID: 12137442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation.
    Aldouri MA; Wonke B; Hoffbrand AV; Flynn DM; Ward SE; Agnew JE; Hilson AJ
    Acta Haematol; 1990; 84(3):113-7. PubMed ID: 2123060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular diastolic dysfunction in congenital chronic anaemias during childhood as determined by comprehensive echocardiographic imaging including acoustic quantification.
    Seliem MA; Al-Saad HI; Bou-Holaigah IH; Khan MN; Palileo MR
    Eur J Echocardiogr; 2002 Jun; 3(2):103-10. PubMed ID: 12114094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of multiple hepatic masses in a young patient with thalassaemia.
    Giovagnoni A; Valeri G; Paci E; Muretto P; Angelucci E
    Pediatr Radiol; 2000 Mar; 30(3):161-4. PubMed ID: 10755753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summaries for patients. Reversibility of liver scarring in patients who are cured of thalassemia.
    Ann Intern Med; 2002 May; 136(9):I36. PubMed ID: 11992322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.